Addition Therapeutics
The role involves producing research‑grade RNA via in vitro transcription and performing a variety of cell‑based assays to evaluate payload performance. The associate will maintain mammalian cell lines, deliver RNA into cells, and generate high‑quality data to support early discovery programs. Collaboration with RNA sciences, protein engineering, and program teams is essential to keep the core experimental engine running.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Addition Therapeutics.
17% below the average for this role
Senior Research Associate, Genome Sciences
Moderna
Research Technician
AbCellera
Research Assistant for the Metabolic Liver Disease Lab
National University of Singapore
Research Associate II
Arc Institute
(StealthCo) Scientist: Biology and Cell Pharmacology
Foresite Labs
Research Assistant
University of Washington Intercollegiate Athletics